A detailed history of Abbrea Capital, LLC transactions in Amgen Inc stock. As of the latest transaction made, Abbrea Capital, LLC holds 8,849 shares of AMGN stock, worth $2.8 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
8,849
Previous 8,900 0.57%
Holding current value
$2.8 Million
Previous $2.53 Million 9.29%
% of portfolio
0.37%
Previous 0.33%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$262.75 - $319.31 $13,400 - $16,284
-51 Reduced 0.57%
8,849 $2.77 Million
Q1 2024

May 07, 2024

BUY
$268.87 - $324.56 $70,175 - $84,710
261 Added 3.02%
8,900 $2.53 Million
Q4 2023

Feb 02, 2024

BUY
$255.7 - $288.46 $72,874 - $82,211
285 Added 3.41%
8,639 $2.49 Million
Q3 2023

Oct 31, 2023

SELL
$218.65 - $271.46 $9,839 - $12,215
-45 Reduced 0.54%
8,354 $2.25 Million
Q2 2023

Aug 01, 2023

BUY
$214.27 - $253.37 $68,994 - $81,585
322 Added 3.99%
8,399 $1.87 Million
Q1 2023

May 11, 2023

BUY
$225.79 - $275.2 $903 - $1,100
4 Added 0.05%
8,077 $1.95 Million
Q4 2022

Feb 08, 2023

BUY
$229.03 - $291.01 $38,935 - $49,471
170 Added 2.15%
8,073 $2.12 Million
Q3 2022

Nov 03, 2022

SELL
$224.46 - $253.15 $71,827 - $81,008
-320 Reduced 3.89%
7,903 $1.78 Million
Q2 2022

Aug 02, 2022

SELL
$230.71 - $256.74 $18,456 - $20,539
-80 Reduced 0.96%
8,223 $2 Million
Q4 2021

Feb 04, 2022

SELL
$198.88 - $227.6 $38,980 - $44,609
-196 Reduced 2.31%
8,303 $1.87 Million
Q3 2021

Nov 04, 2021

BUY
$212.27 - $248.7 $76,417 - $89,532
360 Added 4.42%
8,499 $1.81 Million
Q2 2021

Aug 04, 2021

SELL
$233.58 - $259.14 $7,941 - $8,810
-34 Reduced 0.42%
8,139 $1.98 Million
Q1 2021

May 13, 2021

BUY
$221.91 - $258.6 $21,969 - $25,601
99 Added 1.23%
8,173 $2.03 Million
Q4 2020

Jan 21, 2021

BUY
$216.38 - $257.67 $75,733 - $90,184
350 Added 4.53%
8,074 $1.86 Million
Q3 2020

Oct 20, 2020

SELL
$234.65 - $260.95 $40,594 - $45,144
-173 Reduced 2.19%
7,724 $1.96 Million
Q2 2020

Aug 11, 2020

SELL
$197.81 - $242.74 $85,453 - $104,863
-432 Reduced 5.19%
7,897 $1.86 Million
Q1 2020

Apr 29, 2020

SELL
$182.24 - $241.7 $9,112 - $12,085
-50 Reduced 0.6%
8,329 $1.69 Million
Q4 2019

Feb 11, 2020

BUY
$189.21 - $243.2 $8,514 - $10,944
45 Added 0.54%
8,379 $2.02 Million
Q3 2019

Nov 07, 2019

BUY
$174.11 - $208.62 $13,928 - $16,689
80 Added 0.97%
8,334 $1.61 Million
Q2 2019

Jul 31, 2019

BUY
$166.7 - $195.41 $333 - $390
2 Added 0.02%
8,254 $1.52 Million
Q1 2019

May 08, 2019

BUY
$180.87 - $203.88 $136,014 - $153,317
752 Added 10.03%
8,252 $1.57 Million
Q4 2018

Feb 05, 2019

BUY
$178.4 - $208.25 $56,196 - $65,598
315 Added 4.38%
7,500 $1.46 Million
Q3 2018

Nov 09, 2018

BUY
$185.29 - $208.89 $1,482 - $1,671
8 Added 0.11%
7,185 $1.49 Million
Q2 2018

Aug 08, 2018

BUY
$166.05 - $186.51 $35,700 - $40,099
215 Added 3.09%
7,177 $1.33 Million
Q1 2018

May 10, 2018

BUY
$169.43 - $198.0 $124,022 - $144,936
732 Added 11.75%
6,962 $1.19 Million
Q4 2017

Feb 01, 2018

SELL
$168.79 - $188.59 $10,296 - $11,503
-61 Reduced 0.97%
6,230 $1.08 Million
Q3 2017

Nov 07, 2017

BUY
$167.29 - $191.0 $1.05 Million - $1.2 Million
6,291
6,291 $1.17 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Abbrea Capital, LLC Portfolio

Follow Abbrea Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abbrea Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Abbrea Capital, LLC with notifications on news.